Greenwich LifeSciences
GLSI
50 hedge funds and large institutions have $27.9M invested in Greenwich LifeSciences in 2025 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 16 increasing their positions, 17 reducing their positions, and 8 closing their positions.
131% more capital invested
Capital invested by funds: $12.1M → $27.9M (+$15.8M)
0.67% more ownership
Funds ownership: 8.91% → 9.58% (+0.67%)
6% less repeat investments, than reductions
Existing positions increased: 16 | Existing positions reduced: 17
2% less funds holding
Funds holding: 51 → 50 (-1)
13% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 8
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Credit Agricole
Montrouge Cedex,
France
|
+$916K |
| 2 |
VF
Virtu Financial
New York
|
+$303K |
| 3 |
Man Group
London,
United Kingdom
|
+$295K |
| 4 |
Morgan Stanley
New York
|
+$186K |
| 5 |
State Street
Boston,
Massachusetts
|
+$167K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
-$382K |
| 2 |
Marshall Wace
London,
United Kingdom
|
-$319K |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$163K |
| 4 |
Millennium Management
New York
|
-$154K |
| 5 |
SO
STRS Ohio
Columbus,
Ohio
|
-$151K |
GLSI Hedge Fund Activity: Q4 2025 in Review
50 of the 8,223 institutional investors tracked by Wall St. Rank reported a position in Greenwich LifeSciences (GLSI) for Q4 2025, worth a combined $27.9M — up 131% from $12.1M a quarter earlier.
Sellers outnumbered buyers: 8 funds closed out of GLSI and 7 opened new positions — a net loss of 1 holder — while 17 trimmed existing stakes and 16 added.
The largest buyer was Credit Agricole, opening a new position worth an estimated $916K. The largest seller was Renaissance Technologies, exiting entirely with an estimated $382K sold.
- 50 institutional investors held Greenwich LifeSciences (GLSI) as of Q4 2025, down from 51 in Q3 2025.
- Funds reported $27.9M of Greenwich LifeSciences stock for Q4 2025, up 131% quarter-over-quarter.
- 7 funds opened new Greenwich LifeSciences positions in Q4 2025 and 8 closed out, a net change of -1 holder.
- The largest Greenwich LifeSciences buyer in Q4 2025 was Credit Agricole, an estimated $916K added.
- The largest Greenwich LifeSciences seller in Q4 2025 was Renaissance Technologies, an estimated $382K sold.
Based on aggregated 13F filings for Q4 2025.